Zobrazeno 1 - 10
of 138
pro vyhledávání: '"JOEL I. WARD"'
Autor:
Chris Gast, Eduardo Lopez, Walter A. Orenstein, Ricardo Rüttimann, Bhavesh Borate, Edwin J. Asturias, Ralf Clemens, Xavier Sáez-Llorens, William C. Weldon, Sue Ann Costa Clemens, M. Steven Oberste, Miguel O'Ryan G, Joel I. Ward, Ananda S Bandyopadhyay, Steve Self, Luis Rivera, Mario Melgar, José Jimeno, James Gaensbauer
Publikováno v:
The Lancet. 388:158-169
Summary Background Replacement of the trivalent oral poliovirus vaccine (tOPV) with bivalent types 1 and 3 oral poliovirus vaccine (bOPV) and global introduction of inactivated poliovirus vaccine (IPV) are major steps in the polio endgame strategy. I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad7ed1a13f1d76ab00c87c2f68b9c27a
https://doi.org/10.1016/s0140-6736(16)00703-0
https://doi.org/10.1016/s0140-6736(16)00703-0
Autor:
Maurizio Comanducci, Marzia Monica Giuliani, Joel I. Ward, Duccio Medini, Jie Chen, Mariagrazia Pizza, John J. Donnelly, Alessia Biolchi, George F. Santos, Alessandro Muzzi, Philip Boucher, Rino Rappuoli, Laura Santini, Giuseppe Boccadifuoco, Davide Serruto, Stefania Bambini, E. Richard Moxon, Maria Stella, William Andrews, Carl Frasch
Publikováno v:
Proceedings of the National Academy of Sciences. 107:19490-19495
A unique multicomponent vaccine against serogroup B meningococci incorporates the novel genome-derived proteins fHbp, NHBA, and NadA that may vary in sequence and level of expression. Measuring the effectiveness of such vaccines, using the accepted c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42079eee1a04a464246cb33c5d694950
https://doi.org/10.1073/pnas.1013758107
https://doi.org/10.1073/pnas.1013758107
Autor:
Robert W. Frenck, Patricio Ibáñez, Joel I. Ward, Andrew Ippoliti, Cristina Barolet-Garcia, Konstantinos A. Papadakis, Stephan R. Targan, Nik Agarwal, Gil Y. Melmed, Peter Simpson, Eric A. Vasiliauskas
Publikováno v:
American Journal of Gastroenterology. 105:148-154
The treatment of inflammatory bowel disease (IBD) often includes immunosuppressive medications, which may increase the risk of vaccine-preventable illnesses. We aimed to assess the impact of immunosuppression on immune responses to pneumococcal vacci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::146a3324aaef6b21ee39cb87bddc398e
https://doi.org/10.1038/ajg.2009.523
https://doi.org/10.1038/ajg.2009.523
Autor:
S. Michael Marcy, Jagmohan S. Batra, Kenneth M. Zangwill, Martin Lee, Eileen Eriksen, Joel I. Ward
Publikováno v:
Pediatrics. 123:951-958
OBJECTIVE. There are few recent population-based assessments of vaccine coverage in premature infants available. This study assesses and compares age- and dose-specific immunization coverage in children of different birth weight categories during the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::354f8ff91ccf7b9d7197666f6debb0c2
https://doi.org/10.1542/peds.2008-0231
https://doi.org/10.1542/peds.2008-0231
Autor:
Martin Lee, Joel I. Ward, Sandra Yoder, Claudius U. Meyer, Kathryn M. Edwards, Swei-Ju Chang, Michael D. Decker, Hugues Bogaert, Fred Zepp
Publikováno v:
Clinical and Vaccine Immunology. 14:288-292
Cell-mediated immune (CMI) responses to an acellular pertussis vaccine administered to 49 subjects, a subset of participants in the National Institutes of Health-funded adult acellular pertussis vaccine efficacy trial, were evaluated and compared wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4bd05e766f7c150c6b1241e815be1f9
https://doi.org/10.1128/cvi.00364-06
https://doi.org/10.1128/cvi.00364-06
Autor:
David Michelson, Paula Ray, Ken Huff, Robert F. Davis, Steve Black, Robert T. Chen, Jean C. Hayward, Henry R. Shinefield, Joan Schwalbe, Joel I. Ward, Edwin Lewis, Michael Marcy, John P. Mullooly
Publikováno v:
Pediatric Infectious Disease Journal. 25:768-773
Whole-cell pertussis (wP) and measles vaccines are effective in preventing disease but have also been suspected of increasing the risk of encephalopathy or encephalitis. Although many countries now use acellular pertussis vaccines, wP vaccine is stil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6975e744fa01ae1533a9c87c746e5548
https://doi.org/10.1097/01.inf.0000234067.84848.e1
https://doi.org/10.1097/01.inf.0000234067.84848.e1
Autor:
Martin Lee, Stephen J. Barenkamp, Kathryn M. Edwards, David I. Bernstein, James D. Cherry, Swei-Ju Chang, Wendy A. Keitel, Susan Partridge, John J. Treanor, Robert R. Edelman, Joel I. Ward, David P. Greenberg
Publikováno v:
Clinical Infectious Diseases. 43:151-157
BACKGROUND Acellular pertussis (aP) booster immunizations have been recommended for adolescents and older persons to enhance long-term protection and to possibly reduce community transmission of infections. METHODS This was a multicenter, randomized,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::519b74e95c8669c638a73c8e93f7857b
https://doi.org/10.1086/504803
https://doi.org/10.1086/504803
Autor:
Joel I. Ward, Paul E. Kilgore, John D. Clemens, Luis Jodar, Dang Duc Anh, William A. Kennedy, Batmunkh Nyambat, Hoang T. Long
Publikováno v:
The American Journal of Tropical Medicine and Hygiene. 74:509-515
From March 2000 to February 2002, a population-based study of Haemophilus influenzae type b (Hib) meningitis was conducted among children less than five years of age in Hanoi, Vietnam. Children with suspected bacterial meningitis were referred to hos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::85589bb4451f7e8cc8479fba4980ff36
https://doi.org/10.4269/ajtmh.2006.74.509
https://doi.org/10.4269/ajtmh.2006.74.509
Autor:
Julie Cordova, Ram Yogev, Sylvia H. Yeh, Lane Eubank, Min Shi Lee, Robert E. Walker, Ruth A. Karron, Keith S. Reisinger, Paul M. Mendelman, Mark M. Blatter, Joel I. Ward, Kathleen L. Coelingh, Wendy Chen, David P. Greenberg, Marilyn J. August, Chithra Sangli, Harshvardhan Mehta
Publikováno v:
The Journal of Infectious Diseases. 191:1116-1122
Background. A phase 2 trial was conducted to assess in young infants the safety, tolerability, infectivity, and immunogenicity of multiple doses of an intranasal vaccine using bovine parainfluenza virus type 3 (bPIV3). Methods. One hundred ninety-two
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50b7380828f61d32c960a988e7a462d7
https://doi.org/10.1086/428092
https://doi.org/10.1086/428092
Autor:
Henry R. Shinefield, David S Ogren, Prevention Vaccine Safety Datalink, Loren K. Mell, John P. Mullooly, S. Michael Marcy, Robert L. Davis, Kenneth M. Zangwill, Robert T. Chen, Joel I. Ward, Steven Black
Publikováno v:
Pediatrics. 115:461-467
Objectives. To evaluate compliance with national immunization guidelines among a large cohort of children cared for at health maintenance organizations (HMOs) and to examine effects on immunization status.Methods. A cohort study of 176134 children bo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::189edc8fb3a0e3a7654fbe4167b423ad
https://doi.org/10.1542/peds.2004-1891
https://doi.org/10.1542/peds.2004-1891